"Designing Growth Strategies is in our DNA"

U.S. Human Insulin Market Size, Share & COVID-19 Impact Analysis, By Type (Analog Insulin and Traditional Insulin), By Diabetes Type (Diabetes 1 and Diabetes 2), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI107469

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, By Key Players
    2. Key Market Strategies, By Key Players
    3. Overview of Regulatory Scenario
    4. Impact of COVID-19 on the Market
  5. U.S. Human Insulin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes Type 1
      2. Diabetes Type 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Novo Nordisk A/S
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Eli Lilly and Company
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Sanofi
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. B. Braun Melsungen AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. WOCKHARDT
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. ADOCIA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Gan & Lee Pharmaceuticals USA Corp.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Biocon
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Merck & Co., Inc
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Other Prominent Players
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. Human Insulin Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 2:  U.S. Human Insulin Market Value Share (%), by Type, 2022 & 2030

Figure 3:  U.S. Human Insulin Market Value Share (%), by Diabetes Type, 2022 & 2030

Figure 4:  U.S. Human Insulin Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 5:  U.S. Human Insulin Market Share (%), By Company, 2022

Table 1:  U.S. Human Insulin Market Revenue (USD billion) Forecast, by Type, 2019–2030

Table 2:  U.S. Human Insulin Market Revenue (USD billion) Forecast, by Diabetes Type, 2019–2030

Table 3:  U.S. Human Insulin Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030

U.S. Human Insulin Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 81
Consulting Services
    How will you benefit from our consulting services ?